Logo image of BREZ

BREEZE HOLDINGS ACQUISITION (BREZ) Stock Fundamental Analysis

NASDAQ:BREZ - Nasdaq - US1067621078 - Common Stock - Currency: USD

11.39  -0.06 (-0.48%)

After market: 11.36 -0.03 (-0.26%)

Fundamental Rating

1

Overall BREZ gets a fundamental rating of 1 out of 10. We evaluated BREZ against 0 industry peers in the Unkown industry. The financial health of BREZ is average, but there are quite some concerns on its profitability. BREZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BREZ had negative earnings in the past year.
BREZ had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BREZ reported negative net income in multiple years.
In the past 5 years BREZ always reported negative operating cash flow.
BREZ Yearly Net Income VS EBIT VS OCF VS FCFBREZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA -19.24%
ROE -85.91%
ROIC N/A
ROA(3y)3.1%
ROA(5y)N/A
ROE(3y)-14.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BREZ Yearly ROA, ROE, ROICBREZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80

1.3 Margins

BREZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BREZ Yearly Profit, Operating, Gross MarginsBREZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, BREZ has less shares outstanding
There is no outstanding debt for BREZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BREZ Yearly Shares OutstandingBREZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M
BREZ Yearly Total Debt VS Total AssetsBREZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

BREZ has an Altman-Z score of 0.61. This is a bad value and indicates that BREZ is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for BREZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.61
ROIC/WACCN/A
WACCN/A
BREZ Yearly LT Debt VS Equity VS FCFBREZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.03 indicates that BREZ may have some problems paying its short term obligations.
A Quick Ratio of 0.03 indicates that BREZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
BREZ Yearly Current Assets VS Current LiabilitesBREZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

BREZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -341.24%.
EPS 1Y (TTM)-341.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%173.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BREZ Yearly Revenue VS EstimatesBREZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023
BREZ Yearly EPS VS EstimatesBREZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BREZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BREZ Price Earnings VS Forward Price EarningsBREZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BREZ Per share dataBREZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BREZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BREEZE HOLDINGS ACQUISITION

NASDAQ:BREZ (5/28/2024, 8:04:42 PM)

After market: 11.36 -0.03 (-0.26%)

11.39

-0.06 (-0.48%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-13 2024-05-13
Earnings (Next)08-15 2024-08-15
Inst Owners0.3%
Inst Owner Change-2.27%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.98M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 16.51
P/tB 16.51
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0
BVpS0.69
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.24%
ROE -85.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.1%
ROA(5y)N/A
ROE(3y)-14.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 0.61
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-341.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%173.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.96%
OCF growth 3YN/A
OCF growth 5YN/A